Inclusion compounds of cyclodextrin with sulfur-containing compo

Details Inclusion compounds of cyclodextrin with sulfur-containing compo Inclusion compounds of cyclodextrin with sulfur-containing compo

1982-09-30

1984-11-13

Brown, Johnnie R.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

424180, 424361, C08B 3716, A61K 3173

Patent

active

044827091

DESCRIPTION:

BRIEF SUMMARY
TECHNICAL FIELD OF THE INVENTION

This invention relates to inclusion compounds of cyclodextrin with the compounds of the general formula [I] and salts thereof, ##STR3## wherein A is straight or branched lower alkylene; hydroxyphenyl-lower alkyl, hydroxy-lower alkyl, amino-lower alkyl, guanidino-lower alkyl, imidazolyl-lower alkyl, indolyl-lower alkyl, mercapto-lower alkyl or lower alkylthio-lower alkyl; ring, and each ring may be substituted by phenyl or pyridyl, and phenyl may be resubstituted by hydroxy, lower alkoxy, halogen, nitro or sulfamoyl; ##STR4## said lower alkyl and lower alkoxy having 1 to 6 carbon atoms. The same shall be applied hereinafter.


BACKGROUND OF THE INVENTION

The compound of the formula [I] is a known compound, which shows antihypertensive effect, antirheumatic effect, suppresive effect of liver damage, liquefactive effect of sputum, etc. (Japanese Kokai Koho SHO 54-148783 corresponding to U.S. Pat. No. 4,356,183, Japanese Kokai Koho SHO 55-7255 corresponding to U.S. Pat. No. 4,356,183, U.S. Pat. No. 4,046,889, Japanese Kokai Koho SHO-55-51020 corresponding to U.S. Pat. No. 4,241,086, Japanese Pat. No. 1,066,721 corresponding to U.S. Pat. No. 4,305,958 and Japanese Pat. No. 432,636 corresponding to U.S. Pat. No. 3,246,025) U.S. Pat. Nos. 4,053,651, and 4,347,371.
But, disadvantages of the compound of the formula [I] exist in its less stability and/or low solubility in water, and these problems have not been solved.


DESCRIPTION OF THE INVENTION

This invention relates to inclusion compounds of cyclodextrin with the compounds of the general formula [I] and salts thereof.
The compound of the formula [I] is a known compound, which shows antihypertensive effect, antirheumatic effect, suppresive effect of liver damage, liquefactive effect of sputum, etc.
But, disadvantages of the compound of the formula [I] exist in its less stability and/or low solubility in water.
In order to improve the stability and solubility of the compound of the formula [I], the inventors made the compound of the formula [I] react with cyclodextrin to examine whether it forms the inclusion compound. As the result, the stable inclusion compound could be obtained by the reaction of the compound of the formula [I] with cyclodextrin, and the solubility of some of the resulting inclusion compounds in water became much higher than the original compound.
The method for preparing inclusion compound of this invention is for example as follows.
Cyclodextrin, preferably .beta.-cyclodextrin, is dissolved in water or in a mixture of water and organic solvent which can be miscible with water, and compound [I] or a solution of compound [I] in water-miscible organic solvent is added, preferably by warming. The resulting solution is cooled, concentrated in vacuo or lyophilized to give a inclusion compound.
Water-miscible organic solvent is for example methanol, ethanol, n-propanol, isopropanol, acetone or dimethylformamide.
The ratio of water and organic solvent is chosen according to the solubility of the starting material and the resulting inclusion compound. Inclusion compound of this invention occurs as crystals or a powder and has a constant composition.
In IR spectrum of this inclusion compound, an absorption signal of carboxy group is 1700-1750 cm.sup.-1.
Content of the compound [I] can be calculated by UV absorption spectrophotometry or iodometry. Consequentry, a stability and/or solubility in water of the inclusion compound became much higher than those of compound [I].


Solubility Test

Solubility in water of inclusion compound of cyclodextrin with compound A or compound C is shown below. As the result, the inclusion compound is extremely more soluble in water than the starting compound.


______________________________________ Compound Solubility in water ______________________________________ Compound of Example 1 1.0 g/100 ml Compound of Example 3 0.07 g/100 ml Compound A 0.16 g/100 ml Compound C 0.01 g/100 ml ______________________________________


Stability Test

Preservation test

REFERENCES:
patent: 435618 (1982-10-01), Iwao et al.
patent: 3246025 (1966-04-01), Meta et al.
patent: 4046889 (1977-09-01), Ondetti et al.
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4137420 (1979-01-01), Fujita et al.
patent: 4241086 (1980-12-01), Iwao et al.
patent: 4256761 (1981-03-01), Suh et al.
patent: 4264620 (1981-04-01), Iwao et al.
patent: 4305958 (1981-12-01), Fujita et al.
patent: 4347371 (1982-08-01), Iwao et al.
The Merck Index, 1976, No. 5701.
The Extra Pharmacopoeia, 1977, 27th ed., p. 1822.
M. L. Bender, M. Komiyama, "Cyclodextrin no Kagaku", 4/15/79, pp. 49-57, translation p. 55.
Takamura, Shuichi et al., Chem. Abstracts, vol. 83, 1975, Item 152384e.
Kawamura, Shigeo et al., Chem. Abstracts, vol. 83, 1975, Item 197823p.
Nagai, Tsuneji, Chem. Abstracts, vol. 84, 1976, Item 84:111654v.
Fujita, Kimiji et al., Chem. Abstracts, vol. 91, 1979, Item 91:21117n.

Affiliated with

Also associated with

Rating

Inclusion compounds of cyclodextrin with sulfur-containing compo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inclusion compounds of cyclodextrin with sulfur-containing compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inclusion compounds of cyclodextrin with sulfur-containing compo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2361820